Researchers developed a new laboratory test called LeLISA that uses special proteins called lectins to distinguish between different types of pancreatic cysts. By testing cyst fluid samples against eight different lectins, they found that dangerous mucinous cysts showed strong binding patterns while safer serous cysts showed much weaker signals. This test could help doctors identify which pancreatic cysts need surgery and which ones are safe to monitor over time.